FITC Anti-Human CD66b Antibody[G10F5]

The FITC Anti-Human CD66b Antibody [G10F5] is a highly specific and reliable tool designed for the detection and analysis of CD66b expression in human samples. This antibody is conjugated with fluorescein isothiocyanate (FITC), a widely used fluorochrome known for its exceptional brightness and stability.

CD66b, also known as carcinoembryonic antigen-related cell adhesion molecule 8 (CEACAM8), is a glycosylphosphatidylinositol (GPI)-anchored protein primarily expressed on the surface of neutrophils. It plays a crucial role in neutrophil adhesion and migration, as well as in the regulation of immune responses. CD66b has been implicated in various pathological conditions, including inflammation, infection, and cancer.

The FITC Anti-Human CD66b Antibody [G10F5] has been extensively validated for its specificity and sensitivity in flow cytometry and immunofluorescence applications. It exhibits minimal cross-reactivity with other CEACAM family members, ensuring accurate and reliable results. The high affinity of this antibody for CD66b allows for precise detection and quantification of CD66b-positive cells in complex biological samples.

This antibody is supplied as a liquid formulation in a convenient size of 100 µg, ensuring ample quantity for multiple experiments. It is provided in a ready-to-use format, eliminating the need for time-consuming and error-prone antibody conjugation procedures. The FITC conjugation of this antibody offers excellent signal-to-noise ratio and exceptional photostability, enabling long-term imaging and analysis.

The FITC Anti-Human CD66b Antibody [G10F5] is manufactured under stringent quality control standards to ensure batch-to-batch consistency and reproducibility. It is suitable for use in both research and clinical settings, facilitating the investigation of CD66b expression in various diseases and disorders.

In summary, the FITC Anti-Human CD66b Antibody [G10F5] is a highly specific, reliable, and convenient tool for the detection and analysis of CD66b expression. Its exceptional performance and ease of use make it an invaluable asset for researchers and clinicians alike.